Pancreaticoduodenectomy Clinical Trials

6 recruiting

Pancreaticoduodenectomy Trials at a Glance

6 actively recruiting trials for pancreaticoduodenectomy are listed on ClinicalTrialsFinder across 5 cities in 3 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Minya, Nanjing, and Paris. Lead sponsors running pancreaticoduodenectomy studies include Minia University, Assistance Publique - Hôpitaux de Paris, and Shanghai Zhongshan Hospital.

Browse pancreaticoduodenectomy trials by phase

Treatments under study

About Pancreaticoduodenectomy Clinical Trials

Looking for clinical trials for Pancreaticoduodenectomy? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pancreaticoduodenectomy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pancreaticoduodenectomy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 2

Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery.

Patients Who Undergo Pancreaticoduodenectomy
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School35 enrolled1 locationNCT07514637
Recruiting
Phase 2

Prevention of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy by Preoperative Radiotherapy : a Phase 2 Trial

Pancreatic FistulaPancreaticoduodenectomy
Assistance Publique - Hôpitaux de Paris50 enrolled1 locationNCT07370987
Recruiting
Phase 2

Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate

Pancreas CancerPeriampullary CancerPancreaticoduodenectomy+1 more
Minia University90 enrolled1 locationNCT07230509
Recruiting
Phase 1

Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)

Pancreas CancerPeriampullary CancerPancreaticoduodenectomy+1 more
Minia University30 enrolled1 locationNCT07132541
Recruiting
Not Applicable

Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy

Pancreaticoduodenectomy
Shanghai Zhongshan Hospital322 enrolled1 locationNCT06322680
Recruiting
Not Applicable

Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma

Pancreatic CarcinomaPancreaticoduodenectomyLaparoscopic
Tongji Hospital200 enrolled1 locationNCT03785743